These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29258548)

  • 1. Novel SEA and LG2 Agrin mutations causing congenital Myasthenic syndrome.
    Xi J; Yan C; Liu WW; Qiao K; Lin J; Tian X; Wu H; Lu J; Wong LJ; Beeson D; Zhao C
    Orphanet J Rare Dis; 2017 Dec; 12(1):182. PubMed ID: 29258548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LG2 agrin mutation causing severe congenital myasthenic syndrome mimics functional characteristics of non-neural (z-) agrin.
    Maselli RA; Fernandez JM; Arredondo J; Navarro C; Ngo M; Beeson D; Cagney O; Williams DC; Wollmann RL; Yarov-Yarovoy V; Ferns MJ
    Hum Genet; 2012 Jul; 131(7):1123-35. PubMed ID: 22205389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy.
    Nicole S; Chaouch A; Torbergsen T; Bauché S; de Bruyckere E; Fontenille MJ; Horn MA; van Ghelue M; Løseth S; Issop Y; Cox D; Müller JS; Evangelista T; Stålberg E; Ioos C; Barois A; Brochier G; Sternberg D; Fournier E; Hantaï D; Abicht A; Dusl M; Laval SH; Griffin H; Eymard B; Lochmüller H
    Brain; 2014 Sep; 137(Pt 9):2429-43. PubMed ID: 24951643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Missense Variant in the AGRN Gene; Congenital Myasthenic Syndrome Presenting With Head Drop.
    Karakaya M; Ceyhan-Birsoy O; Beggs AH; Topaloglu H
    J Clin Neuromuscul Dis; 2017 Mar; 18(3):147-151. PubMed ID: 28221305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A valid mouse model of AGRIN-associated congenital myasthenic syndrome.
    Bogdanik LP; Burgess RW
    Hum Mol Genet; 2011 Dec; 20(23):4617-33. PubMed ID: 21890498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital myasthenic syndrome-associated agrin variants affect clustering of acetylcholine receptors in a domain-specific manner.
    Ohkawara B; Shen X; Selcen D; Nazim M; Bril V; Tarnopolsky MA; Brady L; Fukami S; Amato AA; Yis U; Ohno K; Engel AG
    JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32271162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel LG1 Mutations in Agrin Causing Congenital Myasthenia Syndrome.
    Xia P; Xie F; Zhou ZJ; Lv W
    Intern Med; 2022 Mar; 61(6):887-890. PubMed ID: 34433720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an agrin mutation that causes congenital myasthenia and affects synapse function.
    Huzé C; Bauché S; Richard P; Chevessier F; Goillot E; Gaudon K; Ben Ammar A; Chaboud A; Grosjean I; Lecuyer HA; Bernard V; Rouche A; Alexandri N; Kuntzer T; Fardeau M; Fournier E; Brancaccio A; Rüegg MA; Koenig J; Eymard B; Schaeffer L; Hantaï D
    Am J Hum Genet; 2009 Aug; 85(2):155-67. PubMed ID: 19631309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe congenital myasthenic syndromes caused by agrin mutations affecting secretion by motoneurons.
    Jacquier A; Risson V; Simonet T; Roussange F; Lacoste N; Ribault S; Carras J; Theuriet J; Girard E; Grosjean I; Le Goff L; Kröger S; Meltoranta J; Bauché S; Sternberg D; Fournier E; Kostera-Pruszczyk A; O'Connor E; Eymard B; Lochmüller H; Martinat C; Schaeffer L
    Acta Neuropathol; 2022 Oct; 144(4):707-731. PubMed ID: 35948834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-2 Adrenergic Receptor Agonists Enhance AChR Clustering in C2C12 Myotubes: Implications for Therapy of Myasthenic Disorders.
    Clausen L; Cossins J; Beeson D
    J Neuromuscul Dis; 2018; 5(2):231-240. PubMed ID: 29865088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome.
    McMacken GM; Spendiff S; Whittaker RG; O'Connor E; Howarth RM; Boczonadi V; Horvath R; Slater CR; Lochmüller H
    Hum Mol Genet; 2019 Jul; 28(14):2339-2351. PubMed ID: 31220253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations.
    Rodríguez Cruz PM; Cossins J; Estephan EP; Munell F; Selby K; Hirano M; Maroofin R; Mehrjardi MYV; Chow G; Carr A; Manzur A; Robb S; Munot P; Wei Liu W; Banka S; Fraser H; De Goede C; Zanoteli E; Conti Reed U; Sage A; Gratacos M; Macaya A; Dusl M; Senderek J; Töpf A; Hofer M; Knight R; Ramdas S; Jayawant S; Lochmüller H; Palace J; Beeson D
    Brain; 2019 Jun; 142(6):1547-1560. PubMed ID: 31081514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK.
    Gallenmüller C; Müller-Felber W; Dusl M; Stucka R; Guergueltcheva V; Blaschek A; von der Hagen M; Huebner A; Müller JS; Lochmüller H; Abicht A
    Neuromuscul Disord; 2014 Jan; 24(1):31-5. PubMed ID: 24183479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRP4 third β-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner.
    Ohkawara B; Cabrera-Serrano M; Nakata T; Milone M; Asai N; Ito K; Ito M; Masuda A; Ito Y; Engel AG; Ohno K
    Hum Mol Genet; 2014 Apr; 23(7):1856-68. PubMed ID: 24234652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn.
    Müller JS; Baumeister SK; Schara U; Cossins J; Krause S; von der Hagen M; Huebner A; Webster R; Beeson D; Lochmüller H; Abicht A
    Brain; 2006 Oct; 129(Pt 10):2784-93. PubMed ID: 16916845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction.
    Maselli RA; Arredondo J; Cagney O; Ng JJ; Anderson JA; Williams C; Gerke BJ; Soliven B; Wollmann RL
    Hum Mol Genet; 2010 Jun; 19(12):2370-9. PubMed ID: 20371544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutations.
    Cossins J; Burke G; Maxwell S; Spearman H; Man S; Kuks J; Vincent A; Palace J; Fuhrer C; Beeson D
    Brain; 2006 Oct; 129(Pt 10):2773-83. PubMed ID: 16945936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel AGRN Mutation Leads to Congenital Myasthenic Syndrome Only Affecting Limb-girdle Muscle.
    Zhang Y; Dai Y; Han JN; Chen ZH; Ling L; Pu CQ; Cui LY; Huang XS
    Chin Med J (Engl); 2017 Oct; 130(19):2279-2282. PubMed ID: 28937031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
    Cossins J; Liu WW; Belaya K; Maxwell S; Oldridge M; Lester T; Robb S; Beeson D
    Hum Mol Genet; 2012 Sep; 21(17):3765-75. PubMed ID: 22661499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel NtA and LG1 Mutations in Agrin in a Single Patient Causes Congenital Myasthenic Syndrome.
    Wang A; Xiao Y; Huang P; Liu L; Xiong J; Li J; Mao D; Liu L
    Front Neurol; 2020; 11():239. PubMed ID: 32328026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.